CloudWalk Technology's Q3 2026 revenue was 30.2602 million yuan, down 83.75% year-on-year
CloudWalk Technology's single-quarter operating revenue for Q3 2026 was 30.2602 million yuan, down 83.75% year-on-year, with a non-recurring net profit of -29.4592 million yuan. R&D expenses for the period were 18.8067 million yuan, down 57.99% year-on-year, but still accounted for 62.15% of operating revenue, with R&D resources making up more than 60%. The financial report did not disclose the business structure, progress of core products, gross margin, or business outlook.
Topics
Body · AI translation
Serial number Indicator Status
1 Operating revenue 30.2602 million yuan, down 83.75% year-on-year
2 Net profit excluding non-recurring gains and losses -29.4592 million yuan
3 R&D expense ratio R&D expenses 18.8067 million yuan, down 57.99% year-on-year, accounting for 62.15% of operating revenue
According to information disclosed in the 2026 third-quarter report, the company's revenue in the current period declined significantly. Although R&D investment decreased year-on-year, it still maintained a relatively high proportion of revenue, and core technology R&D investment remained at a relatively high priority.
Operating performance declined, R&D investment ratio remained high
Financial report data show that CloudWalk Technology achieved operating revenue of 30.2602 million yuan in the single quarter of the 2026 third quarter, down 83.75% year-on-year; net profit excluding non-recurring gains and losses was -29.4592 million yuan, in a loss-making state. The most noteworthy indicator is the R&D expense ratio: R&D expenses in the current period accounted for 62.15% of operating revenue, reflecting the company's emphasis on technology R&D.
Information related to the business structure and products was not disclosed. Judging from the proportion of R&D investment, the company still takes technology R&D as its core orientation, and R&D resources accounted for more than 60% of operating resources in the current period.
Specific progress and application implementation of core products were not disclosed. R&D expenses in the current period reached 18.8067 million yuan. Although they fell 57.99% year-on-year, they still maintained a high proportion of 62.15% against the backdrop of a sharp decline in revenue, indicating that the company still gives priority to ensuring investment in R&D-related resources during a period of revenue pressure, and that technology iteration and product refinement remain the core work directions at the current stage, consistent with the technology-driven development characteristics of artificial intelligence companies.
Information related to product breakthroughs in the 2026 third quarter was not disclosed, so analysis is not expanded for now.
Analysis related to production capacity and shipment volume was not disclosed, so analysis is not expanded for now.
Gross margin not disclosed, no public performance outlook
Detailed data related to gross margin and net profit in the current period were not disclosed; only net profit excluding non-recurring gains and losses was publicly disclosed as -29.4592 million yuan, and the causes of the related changes were not disclosed.
Information related to management's strategic views and outlook on the company's long-term development was not publicly disclosed, so analysis is not expanded for now.